Perfect! Now I have comprehensive analyst activity data. Let me write the article:
APLS Apellis Pharmaceuticals absorbed the most downgrades among large caps today. The $5.2B biotech climbed 61% year to date yet analysts turned cautious. Target return potential fell to negative 6% showing rare sell conviction.
CNTA Centessa Pharmaceuticals joined the downgrade wave. The $6.2B drug developer surged 59% this year drawing profit-taking calls. Analysts cut forecasts despite strong momentum continuing into April.
NKE Nike saw fresh downgrades as the $66B apparel giant struggled. The stock crashed 30% in 2026 with analysts projecting 50% upside from depressed levels. RSI hit 21 signaling extreme oversold territory.
Upgrades concentrated in tech and gaming. LNW Light & Wonder grabbed bullish calls with 13% upside potential. FWONK Formula One earned upgrades showing 35% return potential as entertainment names drew fresh interest.
HOOD Robinhood Markets attracted upgrades despite falling 38% this year. Analysts see 64% upside potential as the $63B fintech trades near lows. MSFT Microsoft grabbed bullish revisions with 59% upside projected after the stock dropped 23%.
Chinese travel names dominated extreme targets. TCOM Trip.com held analyst upside potential of 953% showing massive divergence between current price and Wall Street projections.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
